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Clinics and pathology 
Disease 
Acute lymphoblastic leukaemia (ALL) 
Phenotype/cell stem origin 
c-ALL or early pre-B immunophenotype. 
Epidemiology 
This type of leukaemia is most common in children 
(20-30% of childhood ALL), peaking at 3-5 years 
although it is rare in infants and has a low incidence in 
adults (5% of adult ALL); excess of females. 
Clinics 
High hyperdiploidy is associated with a low white cell 
count, and FAB type L1 or L2. 
Prognosis 
Prognosis for children is good with long term survival 
of 70%-80%; adults do less well although event free 
survival of 59% at 3 years has been reported; the good 
prognosis is thought to be related to leukaemic cell 
sensitivity to a number of anti-leukaemic drugs and the 
propensity of cells to respond by apoptosis; it is unclear 
why a proportion of patients fail to achieve long term 
remission but there is evidence that higher chromosome 
counts of >56 chromosomes and the presence of 
trisomies 4 and 10 may be associated with a good 
prognosis whereas the presence of i(17q) is clearly 
associated with a poor prognosis. 
Cytogenetics 
Note 
The hyperdiploid karyotype is thought to arise from a 
from a single step mechanism; maintenance of  
heterozygosity has been demonstrated suggesting that 
the hyperdiploidy does not arise from a near haploid 
precursor. 
Cytogenetics morphological 
Patients with hyperdiploidy of >50 chromosomes have 
clones of 51-68 chromosomes; although high 
hyperdiploid clones are rarely identical, they tend to 
show a pattern of chromosome gain with extra copies 
of chromosomes 4, 6, 10, 14, 18 and 21; the gains, 
apart from chromosome 21, more often result in 
trisomy rather than tetrasomy for the gained 
chromosomes. 
Cytogenetics molecular 
High hyperdiploidy can be detected by application of a 
panel of probes which will detect the characteristic 
pattern of gain; this technique can be applied to 
interphase blasts but care must be exercised in 
interpretation and the non-random translocations such 
as t(9;22), t(1;19), t(12;21) and t(4;11) should be 
excluded by application of appropriate probes. 
Additional anomalies 
Translocations and other structural chromosome 
abnormalities are present in approximately half of high 
hyperdiploid cases; duplication 1q is the most common 
additional change; duplication of 1q, deletion of 6q and 
random structural abnormalities have no known 
prognostic impact; however, the presence of non-
random translocations such as t(9;22), t(4;11), t(1;19) 
and t(12;21) indicate that the translocation is most 
likely the primary change and that the hyperdiploidy is 
probably a secondary event; in such cases the 
leukaemia should be classified according to the 
translocation rather than the ploidy group in order to 
assign the correct prognostic implications. 
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